Director Amble Joan Lordi bought 930 BAH shares at $130.90 on 2025-02-05, adding to 56.9K holdings. Stock down -31.2% from 52-week high.
Director Lordi purchased 930 shares at $130.90, representing a modest 1.7% increase to her 56.9K-share position at Booz Allen Hamilton. The timing of this purchase follows a sharp 90-day decline of -30.3% from recent highs, though the stock has stabilized over the past 30 days (-1.6%). Notably, Lordi's prior two open-market purchases at BAH (on 2024-11-22 and 2024-12-06) both experienced negative 30-day returns of -10.8% and -9.4% respectively, suggesting a pattern of purchases made during or shortly after selloffs that have not immediately recovered. The transaction occurs against a company backdrop of solid fundamentals: $2.9B in quarterly revenue, $187.0M net income, and +15.2% annual revenue growth, yet these positives have not arrested the recent stock price decline. This narrow purchase window—roughly 10 weeks after her December buy—warrants observation as to whether it reflects a redeployed conviction signal or a mechanical addition to existing holdings during a period of extended underperformance relative to her prior entry points.
Director Amble Joan Lordi bought 690 BAH shares at $145.66 on 2024-12-06 (total $100.5K); stock now -23.8% from 52-week high.
Director Amble Joan Lordi purchased 690 shares at $145.66, adding to holdings of 55,930 shares post-transaction. The timing coincides with significant price weakness: BAH is currently trading at $141.78, down 22.7% over 30 days and 23.8% from its 52-week high of $186.00. The company's fundamentals remain solid with annual revenue growth of 15.2%, net income of $390,112,000.00, and a P/E of 21.85 on a market cap of $18,115,619,644.32. This represents the director's second open-market purchase at BAH in two weeks, following a prior buy on 2024-11-22, suggesting continued accumulation during a period of market retreat.
Director Amble Joan Lordi bought 2,000 shares of BAH at $147.13; stock down 20.7% from 52-week high and -19.0% over 30 days.
Director Amble Joan Lordi purchased 2,000 shares at $147.13, increasing her holdings from 53,240 to 55,240 shares. The purchase occurred while Booz Allen Hamilton's stock has declined significantly: down 20.7% from its 52-week high of $186.00 and down 19.0% over the past 30 days, though the company maintains strong fundamentals with $3.1B in quarterly revenue, $390.1M in net income, and 15.2% annual revenue growth. The stock is currently trading at $147.46, slightly above the director's purchase price of $147.13. This buy by a sitting director in the context of substantial recent price weakness against stable underlying business performance warrants attention to whether market weakness is creating a buying opportunity or reflects deteriorating near-term prospects.
